BCTX Stock Analysis: Buy, Sell, or Hold?
BCTX - Briacell Therapeutics Corp. Common Shares
$3.50
-0.06 (-1.83%)
▼
5d:
-2.92%
30d:
-14.34%
90d:
-3.72%
HOLD
LOW Confidence
Analysis Updated: Oct 27, 2026 12:00 AM ET
Earnings: Oct 28, 2026
0d
Get Alerted When BCTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BCTX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: BCTX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: BCTX is currently trading at $3.50, which is considered oversold relative to its 30-day fair value range of $3.55 to $4.15.
Technical Outlook: Technically, BCTX is in a uptrend. Immediate support is located at $3.32, while resistance sits at $3.91.
Market Sentiment: BCTX scores 88/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $150.00 (+4113.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BCTX is in a uptrend. Immediate support is located at $3.32, while resistance sits at $3.91.
Market Sentiment: BCTX scores 88/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $150.00 (+4113.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$3.55 -
$4.15
Company Quality Score
68/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (88/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 4113.5% below Wall St target ($150.00)
- CAUTION: Bottoming setup, but lagging the sector by 11% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$3.55 -
$4.15
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$3.32
Resistance Level
$3.91
Current Trend
Uptrend
Technical data as of
Oct 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.05
Wall Street Target
$150.00
(+4113.5%)
Share & Embed Analysis
Last updated: October 28, 2026 3:25 PM ET
Data refreshes hourly during market hours. Next update: 4:25 PM
Data refreshes hourly during market hours. Next update: 4:25 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BCTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
28 analysts |
$92 | 64 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$280 | 51 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
23 analysts |
$108 | 46 HOLD |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
18 analysts |
$70 | 56 HOLD |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$130 | 57 HOLD |
